340B Advocacy Alliance Bulletin - May 14, 2025

Use model letter to submit comments in advance of forthcoming 340B rebate proposal guidance; register for AHA 340B Alliance call May 15

The AHA May 9 urged the Department of Health and Human Services to deny drug companies’ requests to approve their unlawful 340B rebate models. “The 340B Program is a vital lifeline for hospitals, particularly those serving rural and low-income communities,” AHA said. “If HHS authorizes these proposed ‘rebate models,’ it would come at the expense of America’s most vulnerable patients and communities.” HHS recently announced that it will be “in a position to provide guidance” about the drug industry’s proposed use of “rebate models” by the end of May.

Model letter. The AHA has developed a model letter that hospitals and health systems can use to submit their own comments to HHS. The AHA strongly encourages all 340B hospitals to submit their own letters before HHS issues its expected guidance. DOWNLOAD THE LETTER. If you have any questions about the letter, please contact AHA General Counsel and Secretary Chad Golder at cgolder@aha.org.

Register for May 15 call. As a reminder, the AHA 340B Advocacy Alliance will host a call May 15 at 3 p.m. ET to discuss how it plans to advocate against these proposed “rebate models” and how member hospitals can assist in this advocacy effort. This call is for AHA members only, and registration is required to participate. REGISTER NOW. Registration will close at noon ET on May 15. If you have questions about registering, please contact Candice Dailey at cdailey@aha.org.